Planning milestone for the Children’s Cancer Centre

17 Apr 2023, 4:05 p.m.

Graphic of proposed new main entrance at Great Ormond Street Hospital

With Camden Council providing the decision notice for the Children’s Cancer Centre, we have now been granted full planning permission for the scheme.

Designed with the needs of children at its heart, the Children’s Cancer Centre will have outdoor areas and spaces to play, so children can be active and do normal childhood activities. With cancer wards, cancer day care, new theatres and intensive care units co-located, specialist teams will be able to work more closely together and it will be quick and easy for children to access the services they need.

The building will also house new imaging equipment and a specialised chemotherapy pharmacy ensuring we at the forefront of world leading cancer care practice. Alongside the clinical services, the new building gives us the opportunity to create a new entrance for the hospital and to create a new school for the children who come to GOSH.

The new Children’s Cancer Centre will put us in a strong position to build on the decades of work undertaken by our clinicians and the researchers from our academic partner ICH to deliver the very best, kindest and effective treatments for cancer.

Mat Shaw, CEO

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)

By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer